How do i best advocate for a compassionate use drug available in us but not in canada with my current oncologist
TL;DR: Start by having an honest conversation with your oncologist about why you're interested in this drug, then work together to explore whether compassionate use or clinical trial access might be possible for your specific situation.
KEY POINTS:
- Your oncologist needs to understand your medical reasoning and goals—come prepared with specific information about why you believe this drug could help your case
- Compassionate use (also called expanded access) requires your doctor to submit a formal request to the drug manufacturer and FDA, so their buy-in is essential
- Being in Canada doesn't automatically disqualify you; some manufacturers will consider cross-border compassionate use requests, especially if standard options aren't working
- Bring documentation: your pathology report, treatment history, current disease status, and any published data about this drug's effectiveness for your cancer type
- If your current oncologist isn't willing to pursue it, you have the right to seek a second opinion from another oncologist who may be more open to exploring this option
NEXT STEP: Schedule a dedicated appointment with your oncologist (not a routine visit) to discuss this specific drug and ask directly: "Would you be willing to explore compassionate use access for me?"
[[FULL_ANSWER]]
Understanding Compassionate Use (Expanded Access) in Your Situation
Compassionate use—also called "expanded access"—is a pathway that allows patients with serious conditions to access drugs that aren't yet approved in their country, or that haven't been approved for their specific situation. The fact that a drug is available in the US but not yet approved in Canada doesn't automatically make you ineligible, but it does require some specific steps.
How Compassionate Use Actually Works
According to FDA guidance on expanded access programs, the process requires:
-
Your doctor's involvement is non-negotiable. Your oncologist must be willing to submit the request on your behalf. They need to document why they believe this drug is appropriate for your case and why standard approved treatments aren't sufficient.
-
The drug manufacturer must agree. The company that makes the drug has to be willing to provide it outside normal channels. Many manufacturers have compassionate use programs, but they evaluate each request individually.
-
Regulatory approval. The FDA (in the US) and Health Canada (in Canada) both need to approve the request. Health Canada does have expanded access pathways, though the process differs slightly from the US FDA process.
How to Approach Your Oncologist
Come prepared with specifics. Don't just say "I want to try this drug." Instead:
- Bring your pathology report and current disease status documentation
- Have the drug's name, mechanism of action, and any published clinical trial data about its effectiveness for YOUR cancer type
- Explain clearly why you believe this drug could help: Is it because you've failed other treatments? Does your tumor have a specific mutation it targets? Have you read about strong responses in patients like you?
- Ask directly: "I've been reading about [drug name]. Would you be willing to explore whether I might be eligible for compassionate use access?"
Frame it as a collaborative conversation. Your oncologist isn't your adversary—they want you to have effective treatment. But they also need to practice evidence-based medicine. If you can show them credible evidence that this drug might work for your situation, you're more likely to get their support.
What If Your Oncologist Says No?
There are legitimate reasons an oncologist might decline:
- The drug may not be appropriate for your specific cancer type or stage
- There may be better-established options available in Canada
- The evidence supporting its use in your situation may be limited
- Safety concerns specific to your health situation
However, if you believe your oncologist isn't being open-minded, you have the right to seek a second opinion. Contact another oncologist at your cancer center or a different institution and ask specifically: "Would you consider exploring compassionate use access for [drug name] in my case?" Some oncologists are more experienced with expanded access requests than others.
The Cross-Border Complexity
Being in Canada adds a layer of complexity, but it's not insurmountable:
- Some US-based drug manufacturers will work with Canadian patients and Canadian physicians on compassionate use requests
- Health Canada has its own expanded access framework (called the Special Access Programme for drugs and the Special Access Programme for medical devices)
- Your oncologist would need to work with Health Canada's process, which may involve different documentation than the US FDA process
- The timeline may be longer because of the cross-border regulatory requirements
Questions to Ask Your Oncologist
Bring these specific questions to your appointment:
- "Based on my pathology and treatment history, do you think [drug name] could be appropriate for me?"
- "If you think it could help, would you be willing to submit a compassionate use request to the manufacturer and Health Canada?"
- "What information would you need from me to make that decision?"
- "If you don't think it's appropriate, can you explain why? Are there other options I should consider?"
- "If you're not comfortable pursuing this, would you be open to me getting a second opinion from another oncologist?"
Alternative Pathways to Consider
While pursuing compassionate use, also ask about:
- Clinical trials. Is there a trial of this drug open in Canada or the US that you might be eligible for? Some trials allow cross-border enrollment.
- Expanded access programs. Some drug manufacturers have formal programs (not just case-by-case requests) that may be easier to access.
- Similar approved drugs. Are there drugs approved in Canada that work through the same mechanism?
Important Reality Check
Compassionate use requests take time—often weeks to months—and there's no guarantee of approval. Your oncologist needs to believe the potential benefit outweighs the risks and unknowns. Coming in with realistic expectations and solid evidence will serve you better than emotional appeals alone (though your perspective matters too).
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated September 14, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about General
- What are off-label drugs and can they treat my cancer
- Immunotherapy drugs for prostate cancer
- What does everyone use for pain on a hormone blocker?!
- What clinical trials are available for pancreatic cancer
- What treatments are available for peritoneal cancer from the colon
- What support resources are available for caregivers
- Does anyone else have to keep getting blood transfusions I’m getting sick of it now and my oncologist not believing...
- Repurposed drug schedule for metastatic breast cancer